MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Relationship of satisfaction and adherence in remote digital monitoring: Updated results from a clinical drug trial in early Parkinson’s disease

    B. Fehlmann, A. Thomann, W. Popp, F. Lipsmeier, E. Volkova-Volkmar, J. Friess, H. Svoboda, G. Pagano, T. Kilchemann, A. Bamdadian, W. Zago, R. Postuma, M. Lindemann, K. Taylor (Basel, Switzerland)

    Objective: Extend previous findings from a subset of individuals with early Parkinson’s disease (PD) demonstrating high satisfaction levels with daily remote monitoring with a digital…
  • 2022 International Congress

    Continuous wavelet transforms to improve the accuracy of motor assessments of Parkinson’s disease

    T. Kosuri, J. Brasic (Baltimore, USA)

    Objective: We sought to develop a protocol to utilize continuous wavelet transforms (CWTs) to rate the severity of movements to obtain optimal classifications of PD.…
  • 2022 International Congress

    Early Morning Dystonia in Parkinson’s Patients Receiving Opicapone versus Entacapone: a Post-Hoc Analysis of BIPARK-I

    F. Stocchi, J. Ferreira, W. Poewe, O. Rascol, A. Antonini, J-F. Rocha (Rome, Italy)

    Objective: This study evaluated the effect of once-daily opicapone (OPC) 50 mg versus entacapone (ENT) on Early Morning Dystonia (EMD) in Parkinson’s disease patients with…
  • 2022 International Congress

    Functional Movement Disorder Comorbidity in Parkinson’s Disease: a Multicenter Descriptive Study in Spain

    C. Delgado, A. Lopez, E. Lopez, V. Gomez, A. Baltasar, JC. Martinez, A. Alonso, G. Tabar, PJ. Garcia, S. de Lafuente, L. Vela, I. Pareés, M. Kurtis (Madrid, Spain)

    Objective: To describe clinical and demographic characteristics of a Spanish cohort with Parkinson's Disease (PD) and Functional Movement Disorder (FMD) comorbidity. Background: Functional overlay in…
  • 2022 International Congress

    Grey and white matter brain structural alterations in patients with Essential Tremor plus dystonic soft signs

    D. Brinker, O. Granert, I. Tödt, R. Wolke, G. Deuschl, J. Becktepe (Kiel, Germany)

    Objective: Our study aims to examine structural alterations in brain grey and white matter of patients with essential tremor (ET) plus dystonic soft signs compared…
  • 2022 International Congress

    Bilateral Globus Pallidus interna Deep Brain Stimulation for the treatment of chorea-acanthocytosis: A case report from South Africa

    M. Smith, G. Jonsson, A. Ferreira-Correia, N. Duff, M. Zorio (Johannesburg, South Africa)

    Objective: We report on the efficacy of bilateral Globus pallidus interna deep brain stimulation as a treatment for Chorea-acanthocytosis (ChAc). Background: ChAc is an autosomal…
  • 2022 International Congress

    Changes in anticholinergic burden in patients with Parkinson’s disease (PD) after bilateral deep brain stimulation (DBS) of the globus pallidus (GP) and subthalamic nucleus (STN)

    J. Jiao, M. Wilheimi, B. Brumbach, D. Safarpour (Portland, USA)

    Objective: To evaluate the effect of GP and STN DBS upon anticholinergic medication burden in patients with PD. Background: Medications with anticholinergic effects are commonly…
  • 2022 International Congress

    FDG-PET features of Lewy body dementia among patients with amnestic presentations typical for Alzheimer’s disease

    J. Silva-Rodríguez, MA. Labrador-Espinosa, A. Moscoso, M. Schöll, P. Mir, M. Grothe (Sevilla, Spain)

    Objective: To better understand the role of FDG-PET for identifying dementia with Lewy bodies (DLB) in the context of Alzheimer’s disease (AD)-like amnestic presentations, we…
  • 2022 International Congress

    Climb up! Head up! Climbing improves posture in Parkinson’s disease. A randomised controlled trial.

    A. Langer, D. Roth, A. Santer, A. Flotz, J. Gruber, L. Wizany, S. Hasenauer, R. Pokan, P. Dabnichki, M. Treven, S. Zimmel, M. Schmoeger, U. Willinger, L. Gassner, W. Maetzler, H. Zach (Vienna, Austria)

    Objective: We investigated the role of sport climbing in correcting stooped posture in Parkinson Disease patients. Background: Parkinson’s Disease (PD) is a neurodegenerative movement disorder…
  • 2022 International Congress

    Sensor-based gait analysis in the premotor stage of LRRK2 G2019S-associated Parkinson’s disease

    A. Sánchez Rodríguez, C. Tirnauca, D. Salas-Gómez, M. Fernández-Gorgojo, I. Martínez Rodríguez, M. Sierra, I. González Aramburu, D. Stan, A. Gutierrez-González, J. M Meissner, J. Andrés Pacheco, M. Rivera Sánchez, M. Sánchez-Peláez, P. Sánchez Juan, J. Infante (Santander, Spain)

    Objective: To evaluate in a group of asymptomatic carriers of the G2019S mutation of the LRRK2 gene if there are subclinical gait alterations, detectable with…
  • « Previous Page
  • 1
  • …
  • 134
  • 135
  • 136
  • 137
  • 138
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #24970 (not found)
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley